LTRN
Income statement / Annual
Last year (2023), Lantern Pharma Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Lantern Pharma Inc.'s net income was -$15.96 M.
See Lantern Pharma Inc.�s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$174,843.00 |
$154,681.00 |
$97,421.00 |
$3,388.00 |
$1,627.00 |
-$2,544.00 |
| Gross Profit |
-$174,843.00 |
-$154,681.00 |
-$97,421.00 |
-$3,388.00 |
-$1,627.00 |
$2,544.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$11.89 M
|
$8.60 M
|
$7.57 M
|
$2.24 M
|
$953,185.00
|
$572,095.00
|
| General & Administrative
Expenses |
$5.98 M
|
$5.83 M
|
$5.02 M
|
$3.66 M
|
$1.48 M
|
$1.15 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$5.98 M
|
$5.83 M
|
$5.02 M
|
$3.66 M
|
$1.48 M
|
$1.15 M
|
| Other Expenses |
$0.00 |
-$31,548.00 |
$160,550.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$17.88 M |
$14.43 M |
$12.59 M |
$5.91 M |
$2.43 M |
$1.73 M |
| Cost And Expenses |
$17.88 M |
$14.43 M |
$12.59 M |
$5.91 M |
$2.43 M |
$1.73 M |
| Interest Income |
$765,388.00 |
$204,355.00 |
$67,929.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$204,355.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$174,843.00
|
$154,681.00
|
$97,421.00
|
$3,388.00
|
$1,627.00
|
-$2,544.00
|
| EBITDA |
-$15.79 M
|
-$14.42 M
|
-$12.27 M
|
-$5.90 M
|
-$2.43 M
|
-$1.73 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$1.92 M
|
$172,807.00
|
$228,479.00
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$15.96 M |
-$14.26 M |
-$12.36 M |
-$5.91 M |
-$2.43 M |
-$1.73 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$172,807.00 |
-$67,929.00 |
-$202,909.00 |
-$5.00 |
$2,544.00 |
| Net Income |
-$15.96 M |
-$14.09 M |
-$12.30 M |
-$5.91 M |
-$2.43 M |
-$1.73 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.47 |
-1.3 |
-1.13 |
-0.95 |
-0.39 |
-0.28 |
| EPS Diluted |
-1.47 |
-1.3 |
-1.13 |
-0.95 |
-0.39 |
-0.28 |
| Weighted Average Shares
Out |
$10.84 M
|
$10.85 M
|
$10.90 M
|
$6.22 M
|
$6.27 M
|
$6.22 M
|
| Weighted Average Shares
Out Diluted |
$10.84 M
|
$10.85 M
|
$10.90 M
|
$6.22 M
|
$6.27 M
|
$6.22 M
|
| Link |
|
|
|
|
|
|
